December 2017 Heart Health

Letter to the Editor

By

In these articles, the statement “The OnGuard/Tevadaptor system is not considered a closed-system transfer device (CSTD) in its country of manufacture (Israel), and its sale was banned in Sweden as the result of a court ruling” is incorrect and was taken from a source1 that did not provide attribution for its statements.